HRAS antibody (C-Term)
Quick Overview for HRAS antibody (C-Term) (ABIN2285765)
Target
See all HRAS AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 153-184, C-Term
-
Cross-Reactivity
- Human, Mouse (Murine)
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu Mo
-
Characteristics
- HRAS, CT (HRAS, HRAS1, GTPase HRas, H-Ras-1, Ha-Ras, Transforming protein p21, c-H-ras, p21ras, GTPase HRas, N-terminally processed)
-
Purification
- Purified by saturated ammonium sulfate precipitation followed by dialysis against PBS.
-
Immunogen
- HRAS antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 153-184 amino acids from the C-terminal region of human HRAS.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- HRAS (HRas proto-oncogene, GTPase (HRAS))
-
Alternative Name
- HRAS
-
NCBI Accession
- NP_005334
-
UniProt
- P01112
-
Pathways
- p53 Signaling, MAPK Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Hepatitis C, Autophagy, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling, BCR Signaling
Target
-